Molecular characterization of the first fluoroquinolone resistant strains of Streptococcus agalactiae isolated in Brazil

被引:7
作者
Barros, Rosana Rocha [1 ]
Oliveira Kegele, Fabiola Cristina [2 ]
de Paula, Geraldo Renato
de Brito, Monique Araujo
Duarte, Rafael Silva [3 ]
机构
[1] Univ Fed Fluminense, Inst Biomed, BR-24210130 Niteroi, RJ, Brazil
[2] Fundacao Oswaldo Cruz, Rio De Janeiro, RJ, Brazil
[3] Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil
关键词
Fluoroquinolone resistance; Bacteriuria; Genetic diversity; Streptococcus agalactiae; GROUP-B STREPTOCOCCI; ANTIMICROBIAL RESISTANCE; HIGHLY RESISTANT; SUSCEPTIBILITY; EMERGENCE;
D O I
10.1016/j.bjid.2012.05.003
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Three isolates of Streptococcus agalactiae, recovered from residents of the metropolitan area of Rio de Janeiro with significant bacteriuria, were found to be resistant to levofloxacin. Determination of the minimal inhibitory concentration (MIC) confirmed one isolate as intermediate and two as resistant to levofloxacin. No reduction in levofloxacin MIC was observed with reserpine, indicating that resistance was not caused by an efflux mechanism. Typical point mutations were observed in the quinolone resistance determinant region of gyrA and parC. Other point mutations in parC generated novel altered codons: Ser80 -> Pro in the intermediate resistance isolate, and Gly128 -> Asp in a resistant isolate. Through molecular modeling, it was possible to observe that these novel substitutions might not play a role in resistance, since these amino acids were not involved in the antibiotic binding site. Pulsed field gel electrophoresis profiles revealed a non-clonal trend among these isolates. This is the first report of genetic characterization of levofloxacin-resistant S. agalactiae strains in Brazil. (C) 2012 Elsevier Editora Ltda. All rights reserved.
引用
收藏
页码:476 / 478
页数:3
相关论文
共 19 条
[1]  
*CLIN LAB STAND I, 2010, M100S20 CLIN LAB STA
[2]   Susceptibility to antimicrobials and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae from Rio de Janeiro, Brazil [J].
D'Oliveira, REC ;
Barros, RR ;
Mendonça, CRV ;
Teixeira, LM ;
Castro, ACD .
JOURNAL OF MEDICAL MICROBIOLOGY, 2003, 52 (11) :1029-1030
[3]   Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to β-lactam antibiotics [J].
Dahesh, Samira ;
Hensler, Mary E. ;
Van Sorge, Nina M. ;
Gertz, Robert E., Jr. ;
Schrag, Stephanie ;
Nizet, Victor ;
Beall, Bernard W. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (08) :2915-2918
[4]   Distribution of antimicrobial resistance and virulence-related genes among Brazilian group B streptococci recovered from bovine and human sources [J].
Duarte, RS ;
Bellei, BC ;
Miranda, OP ;
Brito, MAVP ;
Teixeira, LM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (01) :97-103
[5]  
Faccone D, 2010, REV ARGENT MICROBIOL, V42, P203
[6]   Perinatal group B streptococcal disease [J].
Heath, Paul T. ;
Schuchat, Anne .
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2007, 21 (03) :411-424
[7]   Quinolone efflux pumps play a central role in emergence of fluoroquinolone resistance in Streptococcus pneumoniae [J].
Jumbe, NL ;
Louie, A ;
Miller, MH ;
Liu, WG ;
Deziel, MR ;
Tam, VH ;
Bachhawat, R ;
Drusano, GL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) :310-317
[8]   First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC [J].
Kawamura, Y ;
Fujiwara, H ;
Mishima, N ;
Tanaka, Y ;
Tanimoto, A ;
Ilawa, S ;
Itoh, Y ;
Ezaki, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (11) :3605-3609
[9]   Structural Basis of Gate-DNA Breakage and Resealing by Type II Topoisomerases [J].
Laponogov, Ivan ;
Pan, Xiao-Su ;
Veselkov, Dennis A. ;
McAuley, Katherine E. ;
Fisher, L. Mark ;
Sanderson, Mark R. .
PLOS ONE, 2010, 5 (06)
[10]   Streptococcus agalactiae highly resistant to fluoroquinolones [J].
Miro, Elisenda ;
Rebollo, Montserrat ;
Rivera, Alba ;
Alvarez, M. Teresa ;
Navarro, Ferran ;
Mirelis, Beatriz ;
Coll, Pere .
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2006, 24 (09) :562-563